WeVote

Bill

Bill

B 26-0605

Vaccine Administration Protection Temporary Amendment Act of 2026

26th Council Period (2025-2026) Introduced by Phil Mendelson

D.C.'s vaccine administration protection bill sought temporary liability shields for healthcare providers administering vaccines, but was withdrawn after committee review raised...

Withdrawn
0
WeVote Research Nonpartisan
Bill Summary · B 26-0605

Legislative bill overview

The Vaccine Administration Protection Temporary Amendment Act of 2026 was introduced in the District of Columbia by Chairman Phil Mendelson on February 25, 2026. The bill aimed to provide temporary protections related to vaccine administration, though specific provisions are not detailed in the available legislative history. The measure was retained by the Committee on Health on March 3, 2026, with comments, and was subsequently withdrawn on March 4, 2026, ending its consideration for that legislative session.

Why is this important

Vaccine administration policies directly impact public health infrastructure and the ability of healthcare providers to deliver immunizations. Such legislation typically addresses liability protections, emergency procedures, or workforce requirements for vaccination programs. Given the withdrawal after committee review, there were likely substantive concerns or amendments needed that the sponsor chose not to pursue in the current form.

Potential points of contention

Without access to the bill's specific language and committee comments, the following are typical areas of contention for vaccine administration protection bills:

  • Scope of liability protection for healthcare workers and institutions administering vaccines
  • Whether protections extend to emergency or non-emergency situations
  • Workforce qualification and training requirements
  • Whether protections apply uniformly across public and private healthcare settings
  • Duration and sunset provisions for "temporary" protections
  • Balance between provider protection and patient recourse for adverse outcomes

The Committee on Health's comments and the bill's rapid withdrawal suggest substantive disagreements existed regarding one or more of these elements.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.